Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 82 (2) , 124-129
Abstract
No abstract availableKeywords
Funding Information
- Foundation for the National Institutes of Health
This publication has 30 references indexed in Scilit:
- Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and DiseaseFrontiers in Immunology, 2013
- An unexpected role for MHC class IINature Immunology, 2011
- Diabetic Mice Display a Delayed Adaptive Immune Response to Mycobacterium tuberculosisThe Journal of Immunology, 2010
- MHC Class II Molecules Enhance Toll-Like Receptor Mediated Innate Immune ResponsesPLOS ONE, 2010
- CD14+ Monocytes Are Vulnerable and Functionally Impaired Under Endoplasmic Reticulum Stress in Patients With Type 2 DiabetesDiabetes, 2009
- The Discovery of Cellular Immunity in the Atherosclerotic PlaqueArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Evolutionary Speculation About Tuberculosis and the Metabolic and Inflammatory Processes of ObesityJAMA, 2009
- Short-term Hyperglycemia in Surgical Patients and a Study of Related Cellular MechanismsAnnals of Surgery, 2006
- TheMycobacterium tuberculosis19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2Infection and Immunity, 2003
- Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosisClinical and Experimental Immunology, 1992